(‘Asterand’ or ‘the Company’) Notification of Interim Results Date: Wednesday 31 August 2011
Asterand plc (“Asterand” or the “Group” – LSE: ATD), a leading supplier of human tissue based solutions to pharmaceutical and biotechnology companies engaged in drug discovery research will announce its Interim Results for the period ended 30 June 2011, on Wednesday 31 August 2011.
- Ends -Contacts: Asterand plcJack Davis, Chairman and Interim Chief Executive Officer Tel: + 44 (0) 1763 211 600 / + 1 (313) 263-0960
John Stchur, Chief Financial Officer As aboveBuchanan CommunicationsLisa Baderoon / Mark Court / Isabel Podda Tel: +44 (0) 20 7466 5000
Daniel Stewart & Company plcAntony Legge Tel: +44 (0) 20 7776 6550
Martin LampshireAbout AsterandAsterand plc is a leading supplier of high quality human tissue and tissue-based services. Our comprehensive approach to human tissue and research services offers pharmaceutical, biotech and diagnostic companies the unique opportunity to have one company meet all of their human biomaterial needs along the continuum of drug discovery and development. Our mission is to accelerate target discovery and compound validation and enable pharmaceutical and biotechnology companies to take safer and more effective drugs into the market. For more information about Asterand, go to www.asterand.com.